In this study we explore whether modulating CD47 signalling in islets, through genetic deletion, knockdown or targeted antibody blockade, imparts resistance to exogenous stressors that would be manifest during islet isolation and transplantation, as well as in individuals with diabetes in whom there is progressively limited beta cell mass and function. This evidence concerns the gene CD47 and diabetes mellitus.